Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

ToxCast Enters Second Phase

by Britt E. Erickson
December 6, 2010 | A version of this story appeared in Volume 88, Issue 49

EPA’s National Center for Computational Toxicology has launched the second phase of its ToxCast program. Begun in 2007, ToxCast aims to predict the toxicity of thousands of chemicals with the help of high-throughput, cell-based assays and computational methods (C&EN, Aug. 13, 2007, page 36). The program has already tested about 300 chemicals, mostly pesticides, during its proof-of-concept phase, using more than 500 fast, automated assays. In the second phase of the program, researchers will screen about 700 additional chemicals, including those found in industrial and consumer products, food additives, and drugs that failed clinical trials because of their toxicity. Several of the new chemicals are significant because they will allow EPA to compare the ToxCast results to human clinical data, not just data from animal toxicology studies. This comparison will allow EPA to determine which ToxCast assays accurately predict human toxicity and disease.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.